Cargando…
A double-blind crossover comparison of the effects of vigabatrin with placebo in the prevention of migraine headache
Twenty-three patients, aged 18‐66 years and suffering from migraine with or without aura, were randomly selected to receive either vigabatrin or matched placebo tablets first for 12 weeks in a double-blind crossover study. Alternative treatment was given after a 4-week washout period. The dose of me...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag Italia
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613231/ http://dx.doi.org/10.1007/s101940200022 |
_version_ | 1782264717942718464 |
---|---|
author | Ghose, Karabi Niven, Brian E. Berry, Dave |
author_facet | Ghose, Karabi Niven, Brian E. Berry, Dave |
author_sort | Ghose, Karabi |
collection | PubMed |
description | Twenty-three patients, aged 18‐66 years and suffering from migraine with or without aura, were randomly selected to receive either vigabatrin or matched placebo tablets first for 12 weeks in a double-blind crossover study. Alternative treatment was given after a 4-week washout period. The dose of medication was titrated to a maximum of 4 tablets (2 g vigabatrin) daily according to patients' tolerance during the first six weeks of each treatment. No further dosage adjustment was made. Apart from rescue medication for migraine, no other drug was permitted. Four patients dropped out and four were excluded for non-compliance. Compared to placebo, vigabatrin decreased the frequency (p=0.017) and severity (p=0.024) of headache modestly. However, it reduced the duration (p=0.019) of headache and migraine index (p=0.012) considerably by 40% and 59%, respectively. No serious adverse effects were observed. Serum vigabatrin levels showed no correlation with the clinical effects. |
format | Online Article Text |
id | pubmed-3613231 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | Springer-Verlag Italia |
record_format | MEDLINE/PubMed |
spelling | pubmed-36132312013-04-01 A double-blind crossover comparison of the effects of vigabatrin with placebo in the prevention of migraine headache Ghose, Karabi Niven, Brian E. Berry, Dave J Headache Pain Original Twenty-three patients, aged 18‐66 years and suffering from migraine with or without aura, were randomly selected to receive either vigabatrin or matched placebo tablets first for 12 weeks in a double-blind crossover study. Alternative treatment was given after a 4-week washout period. The dose of medication was titrated to a maximum of 4 tablets (2 g vigabatrin) daily according to patients' tolerance during the first six weeks of each treatment. No further dosage adjustment was made. Apart from rescue medication for migraine, no other drug was permitted. Four patients dropped out and four were excluded for non-compliance. Compared to placebo, vigabatrin decreased the frequency (p=0.017) and severity (p=0.024) of headache modestly. However, it reduced the duration (p=0.019) of headache and migraine index (p=0.012) considerably by 40% and 59%, respectively. No serious adverse effects were observed. Serum vigabatrin levels showed no correlation with the clinical effects. Springer-Verlag Italia 2002-09 /pmc/articles/PMC3613231/ http://dx.doi.org/10.1007/s101940200022 Text en © Springer-Verlag Italia 2002 |
spellingShingle | Original Ghose, Karabi Niven, Brian E. Berry, Dave A double-blind crossover comparison of the effects of vigabatrin with placebo in the prevention of migraine headache |
title | A double-blind crossover comparison of the effects of vigabatrin with placebo in the prevention of migraine headache |
title_full | A double-blind crossover comparison of the effects of vigabatrin with placebo in the prevention of migraine headache |
title_fullStr | A double-blind crossover comparison of the effects of vigabatrin with placebo in the prevention of migraine headache |
title_full_unstemmed | A double-blind crossover comparison of the effects of vigabatrin with placebo in the prevention of migraine headache |
title_short | A double-blind crossover comparison of the effects of vigabatrin with placebo in the prevention of migraine headache |
title_sort | double-blind crossover comparison of the effects of vigabatrin with placebo in the prevention of migraine headache |
topic | Original |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613231/ http://dx.doi.org/10.1007/s101940200022 |
work_keys_str_mv | AT ghosekarabi adoubleblindcrossovercomparisonoftheeffectsofvigabatrinwithplacebointhepreventionofmigraineheadache AT nivenbriane adoubleblindcrossovercomparisonoftheeffectsofvigabatrinwithplacebointhepreventionofmigraineheadache AT berrydave adoubleblindcrossovercomparisonoftheeffectsofvigabatrinwithplacebointhepreventionofmigraineheadache AT ghosekarabi doubleblindcrossovercomparisonoftheeffectsofvigabatrinwithplacebointhepreventionofmigraineheadache AT nivenbriane doubleblindcrossovercomparisonoftheeffectsofvigabatrinwithplacebointhepreventionofmigraineheadache AT berrydave doubleblindcrossovercomparisonoftheeffectsofvigabatrinwithplacebointhepreventionofmigraineheadache |